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Deep learning neural networks, constructed for the prediction of chemical binding at 79 pharmacologically 
important human biological targets, show extremely high performance on test data (accuracy 92.2 ± 4.2%, 
MCC 0.814 ± 0.093 and ROC-AUC 0.96 ± 0.04). A new molecular similarity measure, Neural Network 
Activation Similarity, has been developed, based on signal propagation through the network. This is 
complementary to standard Tanimoto similarity, and the combined use increases confidence in the 
computer’s prediction of activity for new chemicals by providing a greater understanding of the underlying 
justification. The in silico prediction of these human molecular initiating events is central to the future of 
chemical safety risk assessment and improves the efficiency of safety decision making. 
 




Machine learning algorithms are mathematical models able to learn from data without explicit programming 
from a human expert. The algorithms have gained much attention as high-quality predictors and classifiers. 
Classification tasks in toxicology are often explored using a variety of machine learning algorithms. Some 
examples of this include a support vector machine for predicting liver injury,1, genotoxicity prediction using 
random forests (RFs)2, carcinogenicity predicted using nearest neighbour calculations,3 and using a naive 
Bayes classifier,4 and ensemble methods, combining several classifiers into a single decision-making model 
for hepatotoxicity.5 Deep learning or deep neural networks (DNNs) are a machine learning approach that has 
been gaining attention. These algorithms are extremely powerful but require a large amount of data, and 
high-powered computers for training.6 The power of DNNs has been illustrated in drug discovery, where the 
Merck Molecular Activity Challenge in 2012 was won by an approach using neural networks to make 
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molecular activity predictions.7 In toxicology these networks can be used to aid in risk assessment and safety 
science in predictive toxicology.8 An example of this approach won the Toxicity in the 21st Century (Tox21) 
prediction challenge in 2015,9,10 and deep learning has also been applied to predict drug-induced liver injury11 
and cardiac toxicity.12 A number of studies have shown that DNNs outperform other machine learning 
algorithms on identical prediction tasks7,9,10,13 including direct comparisons to RFs in regression14 and 
classification.15 
In toxicology, computational methods need to be transparent to be accepted by toxicologists, risk assessors 
and regulators.16 Several attempts have been made to do this in the past,17 including by assigning importance 
values to features in the test data by removing features of the test set and observing changes in DNN 
output,18 or by calculating the gradient of DNN output with respect to features in the test set.19,20 Making the 
machine learning methodology more akin to a read-across, in which experimental data on one chemical is 
used in the evaluation of a similar chemical, is a good strategy to increase confidence in the prediction.21 We 
aim to extend these methodologies, in a way appropriate to toxicity prediction, using chemical inputs. 
Human molecular initiating events (MIEs) make good targets for prediction using DNNs. MIEs are initial 
chemical-biological interactions which start adverse outcome pathways (AOPs).22–24 In the past, a wide 
variety of computational methods have been used to predict MIEs. Some of these methods rely on the use of 
chemical substructures as alerts or to define chemical categories for the prediction of molecular activity.25–30 
Some compare chemical similarity and reactivity31 or use decision trees to classify reactivity.32 Some use 
more complex calculations including quantum chemistry to identify reactivity barriers.33 There are also a wide 
variety of mathematical quantitative structure-activity relationships (QSARs) appropriate for this task.16,34 
While machine learning algorithms such as DNNs,13 shallow NNs and decision trees,35 and convolutional 
neural networks36 have been used in ligand-receptor binding binary classification tasks in the past, this is the 
first time DNNs have been applied to predicting MIEs. A wide variety of diverse and important human targets 
were chosen for DNN classifier construction, including the well-known Bowes targets37 and an extended list 
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identified in our previous work38 including targets published by Sipes et al.39 Many of the previously 
published papers on machine learning only provide models for a single biological target or endpoint.1–5,11,12,15 
This limits their usefulness and coverage of human toxicology, which we aim to overcome by constructing 
models for a large number of MIEs. Generating models for this extended list of targets provides a wider 
screen of potential molecular toxicity. 
By constructing binary classification DNNs for these targets we can establish their importance in the 
prediction of MIEs, investigate their working and better understand their predictions, and both compare 
them to other methods of prediction and consider how these approaches can work together to improve their 
predictive power and confidence.  
METHODS 
Data Set.  
Data for 79 pharmacologically important biological targets were extracted from the publicly available 
databases ChEMBL40 and ToxCast41 (Table 1). These targets are a subset of those used in our previous work38 
including targets published by Bowes et al.37 and Sipes et al.39 These targets were chosen as they provide 
valuable toxicological information for risk assessment. The 79 targets used here all had datasets of over 1000 
compounds, which was found to be necessary for DNN construction. ChEMBL and ToxCast were combined to 
provide a relatively balanced dataset with more than 1000 chemicals per target for model construction and 
evaluation, an amount that was found to be required for DNN training. In total 144,109 active and 141796 
inactive unique compound-target relationships were obtained, for a total of 285,905 and a positive data 
percentage of 50.4%. On average this equates to 3530 data points per target. Imbalanced datasets cause 
difficulties for machine learning algorithms,4,12,13,15 and developing a balanced dataset is a key advantage 




Gene Actives Inactives Total 
Acetylcholinesterase AChE 2611 1964 4575 
Adenosine A2a receptor ADORA2A 3943 2082 6025 
Alpha-2a adrenergic receptor ADRA2A 842 1013 1855 
Androgen receptor AR 2637 7283 9920 
Beta-1 adrenergic receptor ADRB1 1260 1080 2340 
Beta-2 adrenergic receptor ADRB2 1943 2012 3955 
Delta opioid receptor OPRD1 3006 1219 4225 
Dopamine D1 receptor DRD1 1350 1990 3340 
Dopamine D2 receptor DRD2 5694 1136 6830 
Dopamine transporter SLC6A3 2509 1916 4425 
Endothelin receptor ET-A EDNRA 1285 1150 2435 
Glucocorticoid receptor NR3C1 3018 6972 9990 
hERG KCNH2 4895 3245 8140 
Histamine H1 receptor HRH1 1275 1105 2380 
Mu opioid receptor OPRM1 3610 2305 5915 
Muscarinic acetylcholine receptor M1 CHRM1 2014 1241 3255 
Muscarinic acetylcholine receptor M2 CHRM2 1633 2032 3665 
Muscarinic acetylcholine receptor M3 CHRM3 1537 1113 2650 
Norepinephrine transporter SLC6A2 2910 1940 4850 
Serotonin 2a (5-HT2a) receptor HTR2A 3757 1033 4790 
Serotonin 3a (5-HT3a) receptor HTR3A 451 1054 1505 
Serotonin transporter SLC6A4 4041 1134 5175 
Tyrosine-protein kinase LCK LCK 1732 523 2255 
Vasopressin V1a receptor AVPR1A 619 1056 1675 
Type-1 angiotensin II receptor AGTR1 806 1179 1985 
RAC-alpha serine/threonine-protein kinase AKT1 2765 1220 3985 
Beta-secretase 1 BACE1 6016 2604 8620 
Cholinesterase BCHE 1400 2145 3545 
Caspase-1 CASP1 1369 3196 4565 
Caspase-3 CASP3 1177 1828 3005 
Caspase-8 CASP8 330 1130 1460 
Muscarinic acetylcholine receptor M5 CHRM5 679 1081 1760 
Inhibitor of nuclear factor kappa-B kinase subunit alpha CHUK 316 1069 1385 
Macrophage colony-stimulating factor 1 receptor CSF1R 1336 1049 2385 
Casein kinase I isoform delta CSNK1D 708 1027 1735 
Endothelin B receptor EDNRB 809 1236 2045 
Neutrophil elastase ELANE 2134 1371 3505 
Ephrin type-A receptor 2 EPHA2 528 1102 1630 
Fibroblast growth factor receptor 1 FGFR1 2163 1207 3370 
Peptidyl-prolyl cis-trans isomerase FKBP1A 354 1006 1360 
Vascular endothelial growth factor receptor 1 FLT1 1088 2077 3165 
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Vascular endothelial growth factor receptor 3 FLT4 674 1081 1755 
Tyrosine-protein kinase FYN FYN 420 1075 1495 
Glycogen synthase kinase-3 beta GSK3B 2549 1256 3805 
Histone deacetylase 3 HDAC3 1051 1139 2190 
Insulin-like growth factor 1 receptor IGF1R 2483 1132 3615 
Insulin receptor INSR 887 1093 1980 
Vascular endothelial growth factor receptor 2 KDR 7816 1579 9395 
Leukotriene B4 receptor 1 LTB4R 350 1030 1380 
Tyrosine-protein kinase Lyn LYN 454 1046 1500 
Mitogen-activated protein kinase 1 MAPK1 6209 11076 17285 
Mitogen-activated protein kinase 9 MAPK9 1227 1088 2315 
MAP kinase-activated protein kinase 2 MAPKAPK2 829 1156 1985 
Hepatocyte growth factor receptor MET 2871 1144 4015 
Matrix metalloproteinase-13 MMP13 2388 1112 3500 
Matrix metalloproteinase-2 MMP2 2938 1677 4615 
Matrix metalloproteinase-3 MMP3 1759 1036 2795 
Matrix metalloproteinase-9 MMP9 2582 1848 4430 
Serine/threonine-protein kinase NEK2 NEK2 298 1057 1355 
P2Y purinoceptor 1 P2RY1 560 1100 1660 
Serine/threonine-protein kinase PAK 4 PAK4 380 1100 1480 
Phosphodiesterase 4A PDE4A 653 1017 1670 
Phosphodiesterase 5A PDE5A 1551 1174 2725 
Phosphatidylinositol 4,5-bisphosphate 3-kinase 
catalytic subunit alpha PIK3CA 4724 2086 6810 
Peroxisome proliferator-activated receptor gamma PPARG 4362 7283 11645 
Protein tyrosine phosphatase non-receptor type 1 PTPN1 1471 2179 3650 
Protein tyrosine phosphatase non-receptor type 11 PTPN11 354 1211 1565 
Protein tyrosine phosphatase non-receptor type 2 PTPN2 339 1206 1545 
RAF proto-oncogene serine/threonine-protein kinase RAF1 1351 1084 2435 
Retinoic acid receptor alpha RARA 356 3249 3605 
Retinoic acid receptor beta RARB 298 3347 3645 
Rho-associated coiled-coil-containing protein kinase I ROCK1 1293 1117 2410 
Ribosomal protein S6 kinase alpha-5 RPS6KA5 224 1036 1260 
NAD-dependent protein deacetylase sirtuin-2 SIRT2 361 1284 1645 
NAD-dependent protein deacetylase sirtuin-3 SIRT3 151 1074 1225 
Proto-oncogene tyrosine-protein kinase Src SRC 2704 1531 4235 
Substance-K receptor TACR2 876 1914 2790 
Thromboxane A2 receptor TBXA2R 978 1922 2900 
Tyrosine-protein kinase receptor TEK TEK 788 1132 1920 
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Table 1. Pharmacological targets analyzed in this work. Data were extracted from ChEMBL version 23 and 
ToxCast. The total test set was 144 109 actives and 141 796 inactives for a total of 285 905 compounds. 
 
ChEMBL (https://www.ebi.ac.uk/chembl/, version 23, data collected April 2018),40 contains more than a 
million annotated compounds comprising over twelve million bioactivities covering in excess of 10 000 
targets, all abstracted from the primary scientific literature.42 Compounds with a confidence score of 8 or 9 
and with reported activities (Ki/Kd/IC50/EC50) less than, or equal to, 10 µM against human protein targets 
were treated as binders and those with activity greater than 10 µM treated as non-binders. These cutoffs 
were chosen to provide chemicals with a pharmacologically relevant activity at a specific, well-defined, 
human target. A cut-off of 10 µM ensures that the compounds have a good degree of biological activity and 
represents a trade-off between activity and dataset size. A confidence score of 8 represents the assignment 
of homologous single proteins, and 9 direct single protein interactions.40 
ToxCast is a high throughput screening library of over nine thousand compounds tested across a thousand 
assays (https://www.epa.gov/chemical-research/toxicity-forecasting, data collected April 2018).41 Data were 
extracted using ToxCast’s in-built binary activity assignments 43 and combined with the ChEMBL data. 
Duplicate data points were removed. This was performed on the molecular structure of each chemical based 
on its atomic connectivity once salt counterions have been stripped, resulting in different tautomers and 
enantiomers being treated as different data points. Where chemicals have contrasting experimental 
datapoints from ChEMBL and ToxCast, the ChEMBL data value was used. All experimental positive 
compounds are binders irrespective of agonistic and antagonistic activity. 
Molecular Representation.  
Chemical fingerprints were generated using RDKit (version 2019.09) for Python.44 To obtain a good balance 
between model performance and computational complexity, the type, radius and length of fingerprints must 
be chosen appropriately. Extended Connectivity Fingerprints (ECFPs) at radius 4 and 6 and several lengths, 
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and MACCS Keys were investigated using data for five biological targets and several network architectures. 
The results of this study are shown in the supporting information (Tables S1 and S2), and the best models 
were produced using ECFP4 fingerprints at length 10000. 
Cross-Validation Strategy. 
The statistical performance of these networks as molecular activity predictors was evaluated using clustered 
five-fold cross-validation.13 This should help to alleviate bias in the ChEMBL and ToxCast data where in some 
cases several molecules are from a structural series, with only small structural differences between them. 
These molecules can then be easy to predict in the test set if others are placed in the training set, 
overestimating model performance. 
Chemical clustering was performed based on chemical fingerprints of the type used as DNN input (ECFP4, 
length 10000) using a maximum distance between any 2 clusters of 0.3. This produces a large number of 
clusters based on the input data. Recombination was then performed to form five clusters of equal size. In 
each case, one cluster was withheld as a test set and a model trained and validated on the remaining four 
clusters, with the training and validation sets shuffled and split randomly into 75% training and 25% 
validation sets.  
DNN Architecture.  
Binary classification DNNs were constructed and trained using TensorFlow in Python 3. For five initial 
biological targets (AChE. ADORA2A, AR, KCHN2 and SLC6A4) the number of hidden layers was varied as either 
one or two, and the number of neurons in each hidden layer was also varied (10, 100 or 1000) to establish 
the best architectures for further biological targets. ReLU (rectified linear unit) activation functions were used 
to provide non-linearity based on an initial investigation into model performance comparing Sigmoid, ReLU 
and combinations of both. The results of this study can be found in the supporting information (Tables S3 and 
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S4). Chemical features were input as discussed above and a binary prediction of biological activity at a target 
was provided as an output.  
In these initial cases (Table 2), networks with two hidden layers of either 100 or 1000 neurons were found to 
perform best, judged based on having i) the highest test set MCC, ii) the highest test set ROC-AUC, iii) the 
highest validation set MCC. For the remaining biological targets, the networks were trained and compared to 
establish the best models. These models were then compared to structural alert (SA) and RF models using 
identical training and test sets to establish which predictors worked best. Further details on the neural 
networks and validation statistics are given in the supporting information.  
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 Training  Validation  Test 
 SE SP ACC MCC ROC-AUC  SE SP ACC MCC ROC-AUC  SE SP ACC MCC ROC-AUC 
AChE                  
[10] 88.7 83.9 86.6 0.726 0.93  84.9 80.7 83.1 0.655 0.90  84.2 78.9 81.9 0.631 0.89 
[100] 90.7 88.4 89.7 0.791 0.96  87.4 83.2 85.6 0.706 0.92  86.2 80.7 83.8 0.670 0.90 
[1000] 88.0 83.7 86.2 0.718 0.93  85.5 78.0 82.3 0.637 0.89  84.4 78.8 82.0 0.632 0.88 
[10,10] 90.7 89.7 90.3 0.802 0.96  86.1 82.9 84.7 0.688 0.92  84.3 82.4 83.5 0.664 0.90 
[100,100] 91.5 91.3 91.4 0.826 0.97  87.1 85.2 86.3 0.721 0.92  85.0 84.2 84.7 0.689 0.91 
[1000,1000] 95.2 96.6 95.8 0.915 0.99  88.0 86.7 87.4 0.744 0.93  84.7 84.0 84.4 0.684 0.92 
                  
ADORA2A      
[10] 97.6 89.9 95.0 0.888 0.98  97.2 90.2 94.7 0.884 0.98  97.2 88.5 94.2 0.871 0.97 
[100] 97.8 92.9 96.1 0.913 0.99  96.9 90.9 94.8 0.886 0.98  97.2 90.2 94.8 0.884 0.98 
[1000] 97.5 90.7 95.2 0.893 0.98  97.2 89.5 94.6 0.879 0.98  97.0 89.1 94.3 0.872 0.97 
[10,10] 97.8 92.7 96.0 0.911 0.99  97.6 90.6 95.3 0.893 0.98  97.0 90.0 94.6 0.880 0.98 
[100,100] 98.1 93.7 96.6 0.924 0.99  96.8 90.8 94.8 0.883 0.98  96.9 90.5 94.7 0.881 0.98 
[1000,1000] 99.0 77.8 91.7 0.817 1.00  97.3 92.4 95.6 0.903 0.98  96.7 91.2 94.8 0.884 0.98 
                  
AR      
[10] 58.0 99.3 88.3 0.691 0.88  59.1 98.9 88.3 0.691 0.87  55.8 99.0 87.5 0.667 0.86 
[100] 69.1 98.7 90.9 0.759 0.91  64.4 98.1 89.1 0.711 0.87  64.5 98.3 89.3 0.715 0.86 
[1000] 65.0 98.6 89.7 0.727 0.89  61.6 98.2 88.5 0.693 0.86  61.5 98.3 88.6 0.695 0.86 
[10,10] 67.1 99.0 90.5 0.750 0.90  62.7 98.5 89.0 0.708 0.86  61.6 98.6 88.8 0.701 0.87 
[100,100] 76.1 99.4 93.2 0.823 0.95  69.2 97.8 90.2 0.740 0.87  68.0 98.1 90.1 0.737 0.87 
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[1000,1000] 73.3 99.4 92.5 0.804 0.94  65.8 97.9 89.3 0.717 0.87  64.4 98.2 89.2 0.713 0.87 
                  
hERG      
[10] 93.5 53.5 77.5 0.529 0.87  91.6 48.2 74.3 0.454 0.82  92.0 46.1 73.7 0.441 0.81 
[100] 94.1 49.9 76.4 0.508 0.86  92.2 45.8 74.2 0.443 0.81  92.9 44.1 73.4 0.438 0.80 
[1000] 89.7 64.3 79.7 0.568 0.87  84.6 59.5 72.7 0.458 0.82  87.0 55.0 74.2 0.450 0.81 
[10,10] 94.1 85.0 90.5 0.800 0.97  86.1 67.0 78.4 0.545 0.86  86.3 63.8 77.3 0.519 0.85 
[100,100] 96.2 90.5 93.9 0.873 0.98  84.9 69.8 78.8 0.555 0.86  85.1 65.5 77.3 0.519 0.84 
[1000,1000] 95.0 87.5 92.0 0.833 0.98  84.2 66.8 77.2 0.520 0.86  83.4 65.5 76.2 0.498 0.84 
                  
SERT      
[10] 99.2 72.4 93.4 0.799 0.98  99.1 66.1 91.7 0.752 0.97  99.0 67.6 92.1 0.760 0.97 
[100] 99.0 89.2 96.9 0.906 0.99  98.4 83.8 95.1 0.856 0.98  98.6 83.1 95.2 0.857 0.98 
[1000] 99.2 77.2 94.4 0.831 0.98  98.8 73.8 93.3 0.797 0.97  99.1 73.9 93.5 0.805 0.97 
[10,10] 99.0 89.7 97.0 0.909 0.99  98.9 82.1 95.1 0.857 0.98  98.7 83.1 95.3 0.858 0.98 
[100,100] 99.4 95.8 98.6 0.959 1.00  98.2 86.1 95.6 0.867 0.98  98.6 86.8 96.0 0.882 0.99 
[1000,1000] 99.4 98.2 99.1 0.975 1.00  98.1 91.1 96.5 0.897 0.99  98.4 90.5 96.6 0.901 0.99 
 
Table 2. Summary of results for various DNN architectures for several targets in initial investigations. Best performing networks on the test data are 
highlighted in red. Full results can be found in the supporting information (Tables S5-S9). The first column represents the NN architecture, showing the 
number of neurons in each hidden layer. SE=sensitivity, SP=specificity, ACC=accuracy, MCC=Matthews correlation coefficient, ROC-AUC=area under 
receiver operating characteristic curve.   
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Neural Network Activation Similarity. 
We calculate the neural network activation similarity (NNAS) from the properties of each of the nodes of a 
trained neural network reacting to the fingerprint of a molecule. For a trained DNN a network activation 
vector, a, is induced by an input fingerprint, x(0), which can be defined as a vector: 
𝐚(𝐱(𝟎)) = (𝑥1
(𝐿𝑖), 𝑥2
(𝐿𝑖), … , 𝑥
𝐾(𝐿𝑖)
(𝐿𝑖) , … , 𝑥1
(𝐿𝑗), 𝑥2




K(L) is the total number of nodes in layer L and different layers can be combined. The similarity between two 
compound’s network activation vectors, a1 and a2 is measured by Euclidean similarity, which relates to 
Euclidean distance DE via the following equations: 
NNAS(𝐚1, 𝐚2) =  
1
1 +  𝐷𝐸 (𝐚1, 𝐚2)
 
 




Where 0 ≤ NNAS ≤ 1 and n is the total number of nodes considered in the calculation. The NNAS provides a 
measure of the similarity of molecules which is different to traditional Tanimoto similarity. As an additional 
comparison point, RF similarity (RFS), was calculated using the Euclidean distance between normalized 
vectors consisting of the 50 most important physicochemical descriptors identified in RF model 
construction.38 This gives an appropriate comparison point based on trained machine learning models, and 
Tanimoto similarity gives a comparison based on chemical similarity and the DNN model inputs. 
All datasets and code used in this project are provided via GitHub 
(https://github.com/teha2/chemical_toxicology). These and generated models are available in the University 
of Cambridge repository (https://doi.org/10.17863/CAM.50429) 
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RESULTS AND DISCUSSION 
Statistical performance for the DNNs constructed is included in the supporting information. A summary of the 
results is shown in Table 3. On average the models show high levels of predictivity, with test accuracy of 92.2 
± 4.2 %, test MCC of 0.814 ± 0.093 and test ROC-AUC 0.96 ± 0.04. This is a high level of performance 
considering several machine learning algorithms struggle to achieve accuracy values above 90% in binary 
classification tasks,1–5 although the difficulty of the task must be considered when comparing model 
performance. The models also do not show excessive levels of overfitting, as can be a problem with DNNs. 
This can be assessed by considering the differences between model performance on the training set and the 
validation/test sets. In this case, the differences are 3.3%, 0.079 and 0.03 for the validation set and 3.6%, 
0.087 and 0.03 for the test set for the accuracy, MCC and ROC-AUC respectively, which can be considered 
modest.  
 Training Data  Validation Data  Test Data 
 SE SP ACC MCC 
ROC-
AUC  SE SP ACC MCC 
ROC-
AUC  SE SP ACC MCC 
ROC-
AUC 
AVERAGE 92.1 96.5 95.8 0.901 0.99  86.9 93.2 92.5 0.822 0.96  86.2 92.9 92.2 0.814 0.96 
SD 8.8 4.2 3.1 0.069 0.02  11.7 5.9 4.1 0.091 0.04  12.1 6.5 4.2 0.093 0.04 
 
Table 3. Average model performance and standard deviation (SD) for the best performing DNN models at 
each target. Full results can be found in the supporting information (Table S10). SE=sensitivity, SP=specificity, 
ACC=accuracy, MCC=Matthews correlation coefficient, ROC-AUC=area under receiver operating characteristic 
curve.   
 
Individual model performance was also considered in relation to the dataset size (Figure 1). Test MCC does 
not appear to increase as dataset size increase, as one might expect, but the standard deviation across the 
five-fold clustered cross-validation, shown by the error bars, does appear to decrease. This does suggest that 
larger datasets will provide more consistent models, even if their performance is similar to datasets of 
around 2000-4000 data points. Notable in Figure 1 are the labelled data points which appear to show low 
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model MCC for quite large datasets. These are the targets KCNH2 and MAPK1, which were identified in our 
previous publication as challenging classifications in this dataset.38 
 
Figure 1. Test MCC vs total Number of Compounds for all biological targets. Error bars shown are standard 
deviations across the five-fold clustered cross-validation. 
 
Positive probability values were also calculated for AR binders using the Softmax function on an optimal 
trained DNN (Figure 2). This functionality allows a prediction made by the DNN to be accompanied by a 
percentage indicating how confident the method is that the chemical is an experimental positive. This 
provides an estimation of the quality of a given binary prediction, with higher probabilities indicating higher 
confidence in a prediction. For example, the confidence in a positive prediction with positive probability 
greater than 0.9 at the AR increases greatly, with almost 99.5% of validation set compounds in this area being 
experimental positives in Figure 2. This helps to increase confidence in the method for a safety science 
decision. Positive probability predictions around 0.5 can be considered untrustworthy and followed up with 
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further calculations or experimental testing, and the threshold for model positive prediction assignment can 
also be adjusted depending on the model’s purpose. Table 4 shows a summary of two such example cases, 
where the threshold during model recall is changed to 0.1 and 0.9 to provide better predictivity of active or 
inactive chemicals respectively. The 0.1 threshold may be of more use in a screening process when you are 
considering which chemicals to advance during product development where no pharmacological effects are 
desired, as any negative predictions made are more likely to be correct.  If you are prioritizing chemicals for 
experimental testing and want to increase the likelihood of finding an active at a particular MIE, the 0.9 
threshold may be more useful for the inverse reason. More extensive results in this study are included in the 
supporting information.  
 
Figure 2. Positive probability curve showing compounds tested at the ADORA2A. Positive probability is the 
probability a compound is active at the ADORA2A calculated by a trained DNN using the Softmax function. 





 0.1  0.9 
 SE SP ACC MCC  SE SP ACC MCC 
AVERAGE 97.0 59.9 79.9 0.619  53.5 98.8 81.3 0.610 
SD 4.2 21.3 10.2 0.137  22.8 1.6 6.6 0.125 
 
Table 4. Average model performance and standard deviation (SD) for the best performing DNN models at 
each target for the validation data sets when adjusted activity thresholds of 0.1 and 0.9 were applied. Full 
results can be found in the supporting information (Tables S11 and S12). SE=sensitivity, SP=specificity, 
ACC=accuracy, MCC=Matthews correlation coefficient.   
 
The best performing DNN for each biological target was compared to models previously generated using SAs 
and RFs.38 In our previous study, the SAs were constructed using structures obtained from a maximal 
common substructure algorithm and selected using Bayesian statistics to iteratively select the best alerts. The 
RF models were based on 200 physicochemical descriptors calculated in RDKit and modelled in sklearn. To 
ensure fairest possible comparison the DNNs were retrained using the same training and test data as the 
other two methods. Average results across the three methods are compared in Table 5, with the distributions 
of these comparisons shown in Figure 3. Further comparisons are available in Table S13 and Figures S1 and S2 
in the supporting information. Overall, the DNNs show a statistically significant increase in MCC over the SAs 
and RFs in a P-value test (α = 0.05). On average the accuracy of models increases by 1.7% compared to SAs 
and 0.67% compared to RFs. The MCC increases by 0.042 and 0.018 respectively. This represents a notable 
improvement, as the number of inaccurate predictions decreases from 8.9% in the SA model to 7.2% in the 
DNN model, a percentage decrease of 19%. For the RF models, the decrease is 9%, from 7.8% incorrect 
predictions to 7.2%. Figure 5 shows that the distributions of model accuracies and MCCs do show overlap 
between the methods with DNN predictions being the highest performing overall. Despite this overlap the 
DNNs do well in direct model comparisons, with 69 DNN models showing higher test accuracies and 71 higher 
test MCC values compared to SAs, and 59 higher test accuracies and 62 higher test MCC values compared to 
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RFs. Of the 632 comparisons in model performance shown in Table S13, the DNNs perform better 459 times 
(73%). 
   Training Set Test Set 
   SE SP ACC MCC SE SP ACC MCC 
SA Average 91.0 95.8 95.0 0.882 84.1 93.5 91.1 0.790 
 SD 7.4 3.5 2.3 0.050 11.6 4.6 4.2 0.096 
          
RF Average 94.9 94.7 96.4 0.915 89.0 90.4 92.2 0.815 
 SD 9.9 5.7 3.1 0.072 11.6 8.1 4.0 0.091 
          
DNN Average 92.3 96.8 95.9 0.904 87.9 93.6 92.8 0.832 
 SD 8.8 3.0 3.1 0.066 10.4 5.9 4.0 0.089 
 
Table 5. Average model performance and standard deviation (SD) for the structural alert (SA), random forest 
(RF) and deep neural network (DNN) models at each target on a consistent training/test set split. Full 
comparisons can be found in the supporting information (Table S13). SE=sensitivity, SP=specificity, 

























Figure 3.  Histograms showing the distribution of test set model performance across the three modelling 
approaches, structural alerts (SAs), random forests (RFs) and deep neural networks (DNNs). 
 
The average test set results for these models can also be considered as a comparison between cross-
validating using a clustered test set and a randomly assigned test set. These differences are shown in Table 6 
and show a small decrease in statistical performance when clustering is used, as is to be expected. The first 
two decimal places of the ROC-AUC values do not change.  
 ACC MCC ROC-AUC 
Clustered Test Set 92.2 0.814 0.96 
Random Test Set 92.8 0.832 0.96 
Difference -0.6 -0.018 0 
 
Table 6. Average statistical performance for models with test sets generated using chemical clustering and 
generated randomly. Clustered statistics are taken from Table 3 and random statistics generated from Table 
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ACC=accuracy, MCC=Matthews correlation coefficient, ROC-AUC=area under receiver operating characteristic 
curve. 
 
Finally, NNAS calculations were made, considering how signals propagate through the hidden layers of a DNN 
when different chemical fingerprints are introduced. This approach is analogous to the use of feature-space 
distance or latent-space distance which has been used to quantitatively assess DNN uncertainty.45 These 
neural network activation similarities between chemicals are considered as potential guidance for read-
across in toxicity risk assessment. NNAS calculations were carried out on the highest performing trained 
DNNs we compared to the SA and RF models using all nodes in all hidden layers of those networks. Typical 
binders from the literature that were not in the model training sets were identified and use for this task. 
Andarine, a typical AR binder,46 amiodarone, a typical KCNH2 binder,47 and 3-amino-4-(2-
dimethylaminomethylphenylsulfanyl-)-benzonitrile (DASB), a typical SLC6A4 binder,48 had their activities 
predicted by the networks and the highest NNAS, Tanimoto similarity49 and RFS compounds from the training 
set were identified. In all three cases, the DNN and the RF correctly predicted the activity of the typical 
binder. Generally, NNAS values are higher than Tanimoto or RF similarities and have a narrower range. Both 
Tanimoto and RF similarities typically range from zero to a high between 0.2 and 0.6. Network similarities 
typically range between 0.8 and 1. In most cases, the compounds with the highest similarities, measured by 
one metric, are different from the compounds with the others. This is reflected throughout the dataset if the 
compounds are ranked based on their network and Tanimoto similarity the RMSE between these ranks is 
always found to be greater than 1000 places. The relationship between Tanimoto and NNAS values is shown 
for all three case studies in Figure 4. These plots show a difference between the similarity values as a lack of 
strong correlation between them. The lack of clear correlation here shows that the networks are not simply 




Figure 4.  A graph showing the relationship between Tanimoto similarity and NNAS values for the three 
typical binders andarine, amiodarone and DASB. 
 
Figure 5 shows amiodarone, an experimentally active KCNH2 binder, and its five most similar chemicals as 
measured by NNAS (A-E), Tanimoto similarity (F-J) and RFS (K-O). In this case, the Tanimoto similar 
compounds all show relatively low similarity (<0.3) and only F appears similar enough to consider making a 
read-across. The NNAS calculation may be more useful in this case, identifying more experimentally active 
compounds (4 vs 3) and more compounds with basic nitrogen atoms attached by linkers to aromatic rings (4 
vs 2), a structural feature associated with biological activity at the KCNH2 target.50 The RFS calculation 
identified 5 experimental positive compounds which all contain the basic nitrogen attached to aromatic ring 
motif, but they all appear to come from a single chemical series – perhaps biasing this result. This example 
suggests the DNN classifier is learning the right kind of features in this difficult classification task. 
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Figure 5.  Amiodarone, a typical KCNH2 binder, and its five most similar neighbours as measured by NNAS (A-
E), Tanimoto similarity (F-J) and RFS (K-O). Starred network activation similarity values have been rounded to 
1.000 but do not represent exact matches. 
 
Figure 6 shows DASB, an SLC6A4 active chemical, and its similar compounds using the same lettering system. 
All identified chemicals are active in this case. The Tanimoto and RFS most similar chemicals show a high level 
of structural similarity to DASB, making them appear as good read-across candidates. They do miss a 
chemical feature picked up by the NNAS chemicals in a pi-bonding group in the lower left-hand corner, which 
is present in A. D also shows a similar feature attached to an aromatic ring. Features such as these can be 
critical to biological activity, and, interestingly, the most network similar compounds pick up these features 
over the arguably more similar features in F-O.  
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Figure 6.  DASB, a typical SLC6A4 binder, and its five most similar neighbours as measured by NNAS (A-E), 
Tanimoto similarity (F-J) and RFS (K-O). 
 
Finally, Figure 7 shows Andarine, an experimentally active chemical at the AR, and its most similar 
compounds. The top five in both the NNAS and Tanimoto lists are all experimentally active, while only two of 
the most similar RFS compounds are. No chemical is in the top five for two of the similarity measures 
showing how they are able to measure different types of similarity. Chemicals F, G and H are highly similar to 
the right-hand side of Andarine, while I and J appear to have more overall similarity with Andarine’s shape. 
The RFS compounds show flexibly attached aromatic rings trifluoromethyl groups and nitro groups. NNAS 
compounds show trifluoromethyl groups in A, B and D and steroidal structures in C and D. Chemical B, in 
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particular, is an interesting case as it shows relatively high Tanimoto similarity (0.364) while appearing quite 
different. In this case, the highest Tanimoto similar chemicals are probably the most useful for identifying a 
read-across relationship. 
 
Figure 7. Andarine, a typical AR binder, and its five most similar neighbours as measured by NNAS (A-E), 
Tanimoto similarity (F-J) and RFS (K-O). Starred network activation similarity values have been rounded to 
1.000 but do not represent exact matches. 
 
Across the three case studies, the concordance between reference chemical experimental activity and 
analogue activities was calculated. When considering the five most similar analogues, network, Tanimoto and 
RF similarities show similar concordances (93%, 87% and 80% respectively). When additional most similar 
cases are considered the NNAS show a steadily more impressive concordance (98%, 72% and 60% for twenty, 
and 98%, 65% and 76% for fifty most similar chemicals). The RFS particularly struggled in the Andarine task – 
identifying only 17 experimental actives in its top 50 most similar compounds, and otherwise should also be 
considered a potentially useful metric when RF classifiers are used. While the most Tanimoto similar 
chemicals can be useful for read-across in a more traditional sense when more cases are considered NNAS is 
 26 
far more useful and does provide insight into the otherwise “black box” NN predictions. All three similarity 
measures provide potentially useful molecular candidates for read-across, and it is useful that they each 
provide different molecules giving more options for toxicologists using NNs and RFs in decision making. It is 
certainly the case that all three similarities should be used together to gain confidence in in silico predictions 
in predictive safety assessment. 
CONCLUSIONS 
In this work, we have constructed DNNs to predict binary activity at human MIEs and developed a new 
similarity measure, NNAS, which increases confidence in the predictions. Key advantages of this work include 
the development of a large number of models covering many human MIEs allowing for predictions across a 
wide expanse of human toxicology, the use of a balanced dataset with an almost equal number of active and 
inactive chemicals, high-quality predictions with a high level of statistical performance which outperforms 
SAs and RF on identical prediction tasks and the introduction of NNAS for use in toxicity safety evaluation to 
increase confidence in the predictions made. The developed networks use chemical fingerprint inputs to 
learn and correctly classify molecules as binders or non-binders. The classifiers show high performance, with 
an average ROC-AUC value of 0.96 ± 0.04 in clustered five-fold cross-validation. The DNNs can also be used to 
provide positive probability values associated with each prediction, and these values can provide additional 
information and confidence values a risk assessor can use in a safety evaluation, including the ability to adjust 
the threshold for activity depending on the prediction task. These DNNs have been considered against SA and 
RF models and show a statistically significant (α = 0.05) improvement in MCC. We introduce a new measure 
of similarity, NNAS which can be used as read-across in a safety evaluation decision. These values provide 
information on how the DNN evaluates the test compound, providing information that Tanimoto similarity 
alone does not and considerably improving our ability to predict adverse outcomes using computational 
methods. 
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The NNAS improves our understanding of these highly predictive DNNs, and so can contribute to the safety 
evaluation of new chemicals. These powerful machine learning approaches can be used alongside other 
computational methods, such as QSARs, SAs or expert systems to provide additional confidence when a 
consensus is reached among predictions. More impact for these in silico methods will assist in reducing the 
reliance on animal experiments, in line with 3Rs objectives.51,52 These methods can also be considered in 
other predictive tasks using DNNs, particularly those using chemical inputs. Neural networks have the 
potential to assist in a number of chemical-based tasks, including biological activity prediction, choice of 
chemical reactants or solvents, and spectra interpretation. As such, understanding gained through methods 
such as this can assist in the discovery of new chemical reactions, the streamlining of chemical synthesis, and 
reduction in cost associated with experimental discovery. 
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